|Bid||76.31 x 800|
|Ask||77.86 x 900|
|Day's range||75.77 - 76.98|
|52-week range||53.22 - 80.59|
|Beta (5Y monthly)||0.48|
|PE ratio (TTM)||27.25|
|Earnings date||27 Jul 2022|
|Forward dividend & yield||2.16 (2.81%)|
|Ex-dividend date||30 Jun 2022|
|1y target est||80.62|
Three little words can make you a lot of money over the long term: Buy and hold. Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie is currently defying gravity.
Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.
Bristol Myers Squibb (BMY) closed the most recent trading day at $76.84, moving -0.21% from the previous trading session.